Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.70 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.51 |
| ▸ | CYP4F2 | P78329 | 6/20 | 0.51 |
| ▸ | CYP4A11 | Q02928 | 6/20 | 0.51 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.49 |
| ▸ | FEN1 | P39748 | 1/20 | 0.49 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3982603 | 0.90 | GPR119 (0.69) | GPR119HDAC1CHEK2CYP4F2CYP4A11 | |
| SCHEMBL14191030 | 0.88 | GPR119 (0.67) | GPR119HDAC1CHEK2CYP4F2CYP4A11 | |
| SCHEMBL15538390 | 0.87 | GPR119 (0.77) | GPR119HDAC1CHEK2CYP4F2CYP4A11 | |
| SCHEMBL3982355 | 0.87 | GPR119 (0.77) | GPR119HDAC1CHEK2CYP4F2CYP4A11 | |
| SCHEMBL14191024 | 0.87 | GPR119 (0.66) | GPR119HDAC1CHEK2CYP4F2CYP4A11 | |
| SCHEMBL14191034 | 0.86 | GPR119 (0.65) | GPR119HDAC1CHEK2CYP4F2CYP4A11 | |
| SCHEMBL387392 | 0.86 | GPR119 (0.69) | GPR119 | |
| SCHEMBL14191036 | 0.86 | GPR119 (0.64) | GPR119HDAC1CHEK2CYP4F2CYP4A11 | |
| SCHEMBL14191020 | 0.85 | GPR119 (0.68) | GPR119HDAC1CHEK2CYP4F2CYP4A11 | |
| SCHEMBL14191032 | 0.85 | GPR119 (0.68) | GPR119HDAC1CHEK2CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080103123-A1 | New compounds | BIOVITRUM (SE) | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103123-A1 | New compounds | GPR119, GPR139, GPR180 | GPR119 1/4885HDAC1 2847/4885CHEK2 4217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.